REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 8th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof among the Company and the Purchasers (the “Purchase Agreement”).
COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of ADVANCED CELL TECHNOLOGY, INC.Advanced Cell Technology, Inc. • September 8th, 2006 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Advanced Cell Technology, Inc., a Delaware corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 8th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 30, 2006 among Advanced Cell Technology, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
AMORTIZING CONVERTIBLE DEBENTUREAdvanced Cell Technology, Inc. • September 8th, 2006 • Pharmaceutical preparations • New York
THIS AMORTIZING DEBENTURE is one of a series of duly authorized and issued Amortizing Convertible Debentures of Advanced Cell Technology, Inc., a Delaware corporation, having a principal place of business at (the “Company”), designated as its Amortizing Convertible Debenture (this debenture, the “Debenture” and collectively with the other such series of debentures, the “Debentures”).
Re: Lock-up LetterPurchase Agreement • September 8th, 2006 • Advanced Cell Technology, Inc. • Pharmaceutical preparations • New York
Reference is made to the Securities Purchase Agreement, dated August 30, 2006 (the “Purchase Agreement”), among Advanced Cell Technology, Inc. (the “Company”) and the purchasers signatory thereto (the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them in the Purchase Agreement.
